Cargando…
Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy
Vascular endothelial growth factor receptors (VEGFRs) are a family of receptor protein tyrosine kinases that play an important role in the regulation of tumor-induced angiogenesis. Currently, VEGFR inhibitors have been widely used in the treatment of various tumors. However, current VEGFR inhibitors...
Autores principales: | Liu, Yun, Li, Yang, Wang, Yuxi, Lin, Congcong, Zhang, Dan, Chen, Juncheng, Ouyang, Liang, Wu, Fengbo, Zhang, Jifa, Chen, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263050/ https://www.ncbi.nlm.nih.gov/pubmed/35799213 http://dx.doi.org/10.1186/s13045-022-01310-7 |
Ejemplares similares
-
Emerging strategies to overcome resistance to third-generation EGFR inhibitors
por: Shi, Kunyu, et al.
Publicado: (2022) -
Enhancement of sciatic nerve regeneration with dual delivery of vascular endothelial growth factor and nerve growth factor genes
por: Fang, Zhiwei, et al.
Publicado: (2020) -
Targeting autophagy-related protein kinases for potential therapeutic purpose
por: Xiang, Honggang, et al.
Publicado: (2020) -
Novel Aurora/vascular endothelial growth factor receptor dual kinase inhibitor as treatment for hepatocellular carcinoma
por: Nakao, Keisuke, et al.
Publicado: (2015) -
Recent progress in dual models
por: Vecchia, P D, et al.
Publicado: (1972)